Medical Weight Loss Programs with
Emerging Treatment Options
Telemedicine Consultations, Treatment Education, and Provider-Guided Care for Eligible Patients
Why Retatrutide?
WHAT RETATRUTIDE MEANS FOR PATIENTS RIGHT NOW
How Triple-Receptor Research Is Being Studied
GLP-1
GLP-1 pathways are involved in appetite, digestion, and blood sugar regulation. A licensed provider can explain how approved GLP-1 medications work and whether they may be appropriate for a patient.
GIP
GIP pathways are being studied for their role in insulin response and metabolic regulation. Clinical relevance depends on the specific medication, patient profile, and treatment setting.
GLUCAGON RECEPTOR
Glucagon receptor activity is being studied for its role in energy balance and metabolism. Claims about targeted fat loss or midsection fat loss should not be made.
Together, these pathways are part of ongoing clinical research. Individual treatment decisions should be based on medical history, current evidence, medication availability, and provider judgment.
California Trim Clinic offers Licensed-Provider Consultations for Medical Weight Loss.
If Medication-Based Care is Appropriate, your Provider can Discuss Available Treatment Options, Potential Benefits, Risks, and Limitations. Compounded Medications, when Legally Available and Prescribed for a Patient-Specific Need, are not FDA-Approved.
Understanding Different Medical Weight Loss Pathways
| Feature | Retatrutide | Semaglutide | Tirzepatide |
|---|---|---|---|
| Current Status | Investigational; not FDA-approved | FDA-approved options exist for certain patients | FDA-approved options exist for certain patients |
| Pathway Focus | GLP-1, GIP, and glucagon activity under study | GLP-1 receptor pathway | GLP-1 and GIP receptor pathways |
| Patient Conversation | Education only; not an approved treatment option | May be reviewed by a licensed provider when appropriate | May be reviewed by a licensed provider when appropriate |
| Best Next Step | Start with questions and care team guidance | Review benefits, risks, and eligibility | Review benefits, risks, and eligibility |
Provider-Guided. Transparent. Telemedicine-Based.
Your care begins with a licensed-provider review. When medication is prescribed, fulfillment depends on clinical eligibility, legal availability, and pharmacy requirements. Patients should never purchase injectable medications from research supply websites or unverified online sellers.
Every care plan should be based on your health history, provider review, realistic expectations, and clear follow-up guidance.
Start With a Licensed Medical Weight Loss Consultation
Prescription treatment is available only when a licensed medical provider determines it is medically appropriate. Some medications discussed by providers may be compounded pursuant to a patient-specific prescription when legally available. Compounded Medications are not FDA-Approved, and FDA does not Evaluate Compounded Medications for Safety or Effectiveness.